NACL Industries share price & results
- Jun 2026
- Sept 2026
Hyderabad agrochemical maker of technical actives and 66+ branded crop-protection formulations for farmers.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 383 | −14.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 11.0 | +3.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 21.0 | +61.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 4.86 | +28.3 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | -8.44 | −43.9 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 11.94 | +58.8 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance −45.7% 1Y
1Y: ₹208.25 on 24 Oct 2025 → ₹113.02. High ₹243.02 (13 Jul 2026), low ₹113.02 (27 Oct 2026).
- Previous close
- ₹113.09
- Market cap
- ₹2.6k Cr
- 52-week range
- ₹113.02 – ₹243.02
- One year
- −43.55%
- Price to earnings (TTM to Jun 2026)
- 98.11×
- Return on equity (TTM to Jun 2026)
- 4.86%
Overview
- Symbol
- NSE:NACLIND
- Sector
- Chemicals
- Industry
- Commodities
- Exchange
- NSE
- Currency
- INR
What NACL Industries Limited does
Based on the company's own presentations, annual report and earnings calls.
NACL Industries manufactures technical-grade agrochemical active ingredients — insecticides, herbicides, fungicides and plant growth regulators — and converts them in-house into branded formulations sold to farmers through its own direct-to-retail distribution network. It runs an integrated crop-protection value chain spanning R&D, technical manufacturing, formulation/packaging, and distribution, serving both a domestic farmer base and B2B/export customers including multinational agrochemical companies. The company also undertakes custom and contract manufacturing for global agrochemical majors.
Segments
- Technical (Active Ingredients)
- Formulations
- Manufacturing plants (technical)
- 4
- Installed technical manufacturing capacity
- 17,000 TPA
- Formulation/packaging capacity
- 12,000 KL liquids, 5,600 MT powders, 35,000 MT granules
- Branded products
- 66+
- NACL stock points (India)
- 47
- Farmer customers served
- 5 million
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
What the filings say
Net profit, year on year: +62% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 440 | 268 | 201 | 448 | 457 | 318 | 361 | 383 |
| Expenses | 400 | 294 | 275 | 410 | 412 | 312 | 348 | 342 |
| Operating profit | 41 | -26 | -74 | 38 | 45 | 7 | 13 | 41 |
| Operating margin | 9.0% | −10.0% | −37.0% | 8.0% | 10.0% | 2.1% | 3.7% | 11.0% |
| Other income | 4 | 2 | 30 | 1 | -17 | 0 | 2 | 2 |
| Interest | 17 | 15 | 14 | 14 | 13 | 12 | 7 | 6 |
| Depreciation | 7 | 7 | 8 | 7 | 8 | 8 | 9 | 9 |
| Profit before tax | 20 | -47 | -66 | 18 | 6 | -14 | -1 | 28 |
| Tax rate | 27.0% | −22.0% | −24.0% | 27.0% | 60.0% | −25.0% | −28.0% | 26.0% |
| Net profit | 15 | -36 | -50 | 13 | 3 | -10 | -1 | 21 |
| EPS (₹ per share) | 0.64 | -1.56 | -2.14 | 0.56 | 0.11 | -0.43 | -0.04 | 0.89 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 2,119 | 1,778 | 1,234 | 1,584 |
| Expenses | 1,927 | 1,762 | 1,298 | 1,482 |
| Operating profit | 193 | 17 | -63 | 103 |
| Other income | 12 | 10 | 39 | -14 |
| Interest | 47 | 76 | 64 | 46 |
| Depreciation | 28 | 28 | 29 | 32 |
| Profit before tax | 128 | -76 | -120 | 9 |
| Net profit | 95 | -59 | -92 | 5 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 20 | 20 | 20 | 20 | 20 | 23 |
| Reserves | 469 | 554 | 491 | 407 | 424 | 660 |
| Borrowings | 531 | 724 | 789 | 399 | 502 | 312 |
| Other liabilities | 496 | 616 | 518 | 397 | 542 | 369 |
| Total liabilities | 1,516 | 1,914 | 1,818 | 1,223 | 1,487 | 1,364 |
| Fixed assets | 238 | 402 | 439 | 439 | 465 | 459 |
| Capital work in progress | 116 | 71 | 47 | 43 | 2 | 18 |
| Investments | 13 | 14 | 15 | 16 | 8 | 8 |
| Other assets | 1,148 | 1,427 | 1,318 | 726 | 1,012 | 879 |
| Total assets | 1,516 | 1,914 | 1,818 | 1,223 | 1,487 | 1,364 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 83 | -124 | -20 | 50 | 469 | -104 |
| Cash from investing | 14 | -163 | -143 | -38 | 4 | -58 |
| Cash from financing | -113 | 290 | 134 | -22 | -448 | 108 |
| Net cash flow | -16 | 2 | -28 | -9 | 25 | -55 |
| Free cash flow | 67 | -262 | -166 | 11 | 438 | -134 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 103 | 118 | 133 | 157 | 81 | 106 |
| Inventory days | 100 | 124 | 112 | 99 | 109 | 96 |
| Days payable | 120 | 112 | 110 | 93 | 118 | 96 |
| Cash conversion cycle | 83 | 129 | 135 | 162 | 73 | 105 |
| Working capital days | 50 | 44 | 38 | 16 | -24 | 33 |
| Return on capital employed | 17.0% | 15.0% | 15.0% | 0.0% | −8.0% | 8.0% |
| Dividend payout | 15.0% | 15.0% | 15.0% | 0.0% | 0.0% | 0.0% |
Where revenue comes from
The businesses behind the company’s reported revenue.
operting revenue contributes 100.0% of reported segment revenue.
Year ended 31 Mar 2019 · Consolidated
- operting revenue 100.0%
₹891.21 crore
| Business segment | Revenue · ₹ crore | Share |
|---|---|---|
| operting revenue | 891.21 | 100.0% |
Share = segment revenue ÷ total segment revenue, before intersegment adjustments.
How these numbers add up
- Total segment revenue
- ₹891.21 crore
- Intersegment adjustment
- ₹0.00 crore
- Net segment revenue
- ₹891.21 crore
Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.
Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.
Ownership
Who owns it
Promoters hold 53.68% as of Sept 2026; institutions cut 0.34 pts since Jun 2026.
- Promoters 53.68%
- Foreign institutions 0.24%
- Domestic institutions 0.83%
- Public 45.25%
Who bought this quarter
since Jun 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- +1.28 pp 4.62% held
The same filing shows 0 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Sep 2026 filing
Every holder of NACL Industries Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 53.68% | unchanged | |
| 7.84% | unchanged | |
| 7.84% | unchanged | |
| 4.62% | +1.28 pp | |
| 1.40% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for NACL Industries Limited
Free account: one company. Everything above stays public.
Write why you follow NACL Industries Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Chemicals companies
- CH
CHEMPLASTSChemplast Sanmar Limited - NF
NFLNational Fertilizers Limited - JU
JUBLCPLJubilant Agri and Consumer Products Limited - BE
BEPLBhansali Engineering Polymers Limited - BH
BHAGCHEMBhagiradha Chemicals & Industries Limited - DD
DDEVPLSTIKDdev Plastiks Industries Limited - NO
NOCILNOCIL Limited - RO
ROSSARIRossari Biotech Limited
Learn to analyse NACL Industries Limited
Guides on how to read this kind of business and the numbers that matter.